-- 光榮特庫摩(東京證券交易所代號:3635)2025財年歸屬於母公司股東的淨利年增14%,達428億日圓,高於上年的376億日圓。 根據週一提交給東京證券交易所的文件,這家娛樂和電子遊戲公司的每股收益從上年的113.65日圓增加到131.67日圓。 截至3月31日的整個財年,淨銷售額年增6.3%,達到884億日元,高於上年的832億日圓。 在另一份揭露文件中,光榮特庫摩將末期股利從先前預測的每股43日圓上調至每股66日圓,將於6月19日起發放。 該公司預計2026財年歸屬於股東的淨利為310億日元,基本每股收益為95.38日元,淨銷售額為900億日元。 光榮特庫摩計畫派發每股48日圓的年終股息,低於前一年的股利。
Related Articles
Stifel Canada Hikes Aritzia Price Target to $158.00
Stifel Canada is expecting another strong quarter from Aritzia (ATZ.TO) when it reports its fiscal fourth-quarter earnings on May 7.Analyst Martin Landry, who is raising his price target on the company's shares by $8.00 to $158.00 and maintaining a buy rating, is also hiking comparable sales growth expectation by 700bps to 21% Y/Y, higher than consensus of 18%."We expect Aritzia to introduce a FY27 guidance higher than current consensus expectations, potentially driving upwards earnings revisions," Landry adds. Aritzia shares touched an all-time high on Friday as investors are pricing the company's strong operational performance.Landry also expects earnings per share growth of 34% Y/Y in fiscal 27, higher than peers.Price: $139.87, Change: $-3.34, Percent Change: -2.33%
HCA Healthcare Pressure Expected to Persist Through Q2 on Managed Care Rotation, RBC Says
HCA Healthcare (HCA) may face near-term pressure through at least the first half as investors rotate toward managed care, although better trends in March and in-line exchange dynamics support the longer-term outlook, RBC Capital Markets said.The company's weaker-than-expected Q1, driven by lower respiratory volume and weather-related disruption, has increased near-term concern around hospital volumes and patient mix.RBC said in a Sunday note that it expects Friday's share price decline to persist through Q2 as management works to demonstrate execution against growth targets and as investors await further clarity on the impact of ePTC expiry.The investment firm said March volumes improved meaningfully while exchange-related pressure remains manageable. HIX declines reflect both lost volume and patients in grace periods already incorporated into bad debt reserves. Surgical and outpatient trends remain broadly consistent with its full-year outlook, according to the note.RBC reiterated its outperform rating and lowered its price target to $534 from $593, citing increased caution on near-term hospital volume and mix dynamics and a broader rotation toward managed care.Price: $439.41, Change: $+6.95, Percent Change: +1.61%
BluEnergies Announces DTC Eligibility
BluEnergies (BLU.V) shares are now eligible for electronic clearing and settlement in the United States through the Depository Trust Company (DTC), BluEnergies said on Monday.The company's shares recently began trading on the OTCQX Best Market under the ticker BLUGF, it added."Obtaining DTC eligibility marks an important step in expanding BLU's investor base and enhancing accessibility for shareholders," said chief executive Craig Steinke. "For investors, DTC eligibility is a key milestone that streamlines electronic trading and supports improved liquidity, which is especially important as we advance the development of our assets in the Harper Basin, Liberia and Gulf of America and continue to build long-term value across our portfolio."The company's shares were last seen down $0.09, or 3.1%, to $2.73 on the TSX Venture Exchange.Price: $2.73, Change: $-0.09, Percent Change: -3.19%